Multiple-viruses IVDs

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Dostupné s:

Abbott Australasia Pty Ltd Molecular Division

Třída:

Class 3

Výrobce:

Abbott Molecular Inc 1300 East Touhy Avenue, Des Plaines, Illinois, 60018 United States Of America

Terapeutické oblasti:

CT702 - Multiple-viruses IVDs

Terapeutické indikace:

The Abbott Resp-4-Plex assay is a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the qualitative detection and differentiation of RNA from influenza A virus (flu A), influenza B virus (flu B), Respiratory Syncytial Virus (RSV), and SARS-CoV-2 in nasopharyngeal (NP) swab specimens collected by a healthcare provider, from individuals with signs and symptoms of respiratory tract infection.

Stav Autorizace:

A

Datum autorizace:

2022-04-01